If granted, the test’s approval process could be accelerated. The submission comes after two clinical studies conducted on the test showed consistently positive results, according to a July 9 news release from Mainz.
The test combines a traditional fecal immunochemical test with special biomarkers, alongside artificial intelligence and machine-learning algorithms.
